|
WO2010081856A1
(en)
|
2009-01-14 |
2010-07-22 |
Ablynx Nv |
Pulmonary administration of immunoglobulin single variable domains and constructs thereof
|
|
BRPI0617664B8
(pt)
|
2005-10-21 |
2021-05-25 |
Chugai Pharmaceutical Co Ltd |
uso de um anticorpo que reconhece a il-6 para a produção de uma composição farmacêutica para tratar o enfarte do miocárdio ou suprimir a remodelagem ventricular esquerda depois do enfarte do miocárdio
|
|
WO2007116962A1
(ja)
|
2006-04-07 |
2007-10-18 |
Osaka University |
筋再生促進剤
|
|
US8080248B2
(en)
|
2006-06-02 |
2011-12-20 |
Regeneron Pharmaceuticals, Inc. |
Method of treating rheumatoid arthritis with an IL-6R antibody
|
|
CA2652976C
(en)
|
2006-06-02 |
2015-08-11 |
Regeneron Pharmaceuticals, Inc. |
High affinity antibodies to human il-6 receptor
|
|
EP2057191A1
(en)
|
2006-08-18 |
2009-05-13 |
Ablynx N.V. |
Amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of deseases and disorders associated with il-6-mediated signalling
|
|
JP2010512734A
(ja)
*
|
2006-12-13 |
2010-04-30 |
アブリンクス エン．ヴェー． |
Ｉｌ−６／ｉｌ−６受容体複合体等受容体介在性シグナル伝達に関与する複合体に特異的なポリペプチド
|
|
US9512236B2
(en)
|
2006-12-19 |
2016-12-06 |
Ablynx N.V. |
Amino acid sequences directed against GPCRS and polypeptides comprising the same for the treatment of GPCR-related diseases and disorders
|
|
CN101646459B
(zh)
|
2007-01-23 |
2014-02-12 |
国立大学法人信州大学 |
慢性排斥反应抑制剂
|
|
BRPI0813645A2
(pt)
|
2007-06-25 |
2014-12-30 |
Esbatech Alcon Biomed Res Unit |
Métodos para modificar anticorpos, e anticorpos modificados com propriedades funcionais aperfeiçoadas
|
|
WO2009010539A2
(en)
*
|
2007-07-19 |
2009-01-22 |
Ablynx. N.V. |
Receptor for interleukin-6 (il-6) from macaca fascicularis
|
|
WO2009095489A2
(en)
*
|
2008-02-01 |
2009-08-06 |
Ablynx N.V. |
Improved amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of diseases and disorders associated with il-6-mediated signalling
|
|
CA2717015A1
(en)
*
|
2008-03-05 |
2009-09-11 |
Ablynx Nv |
Novel antigen binding dimer-complexes, methods of making and uses thereof
|
|
WO2009127691A1
(en)
|
2008-04-17 |
2009-10-22 |
Ablynx N.V. |
Peptides capable of binding to serum proteins and compounds, constructs and polypeptides comprising the same
|
|
JP5544290B2
(ja)
|
2008-06-05 |
2014-07-09 |
独立行政法人国立がん研究センター |
神経浸潤抑制剤
|
|
DK2285408T3
(en)
|
2008-06-05 |
2019-02-04 |
Ablynx Nv |
AMINO ACID SEQUENCES AGAINST COATING PROTEINS IN A VIRUS AND POLYPEPTIDES INCLUDING THESE FOR TREATMENT OF VIRUSAL DISEASES
|
|
US8444976B2
(en)
|
2008-07-02 |
2013-05-21 |
Argen-X B.V. |
Antigen binding polypeptides
|
|
EP2313436B1
(en)
|
2008-07-22 |
2014-11-26 |
Ablynx N.V. |
Amino acid sequences directed against multitarget scavenger receptors and polypeptides
|
|
TWI440469B
(zh)
|
2008-09-26 |
2014-06-11 |
Chugai Pharmaceutical Co Ltd |
Improved antibody molecules
|
|
CA2740561C
(en)
*
|
2008-10-14 |
2021-01-19 |
National Research Council Of Canada |
Bsa-specific antibodies
|
|
CN102307902B
(zh)
*
|
2008-12-10 |
2016-02-24 |
埃博灵克斯股份有限公司 |
用于治疗与血管发生相关的疾病和病症的针对血管生成素/Tie系统的氨基酸序列和包括其的多肽
|
|
CA2747644C
(en)
|
2008-12-19 |
2023-01-24 |
Ablynx N.V. |
Method for generation of immunoglobulin sequences
|
|
PE20120586A1
(es)
*
|
2009-01-29 |
2012-06-17 |
Abbott Lab |
Proteinas de union a il-1
|
|
US9265834B2
(en)
|
2009-03-05 |
2016-02-23 |
Ablynx N.V. |
Stable formulations of polypeptides and uses thereof
|
|
US10005830B2
(en)
|
2009-03-05 |
2018-06-26 |
Ablynx N.V. |
Antigen binding dimer-complexes, methods of making/avoiding and uses thereof
|
|
TWI457134B
(zh)
*
|
2009-03-19 |
2014-10-21 |
Chugai Pharmaceutical Co Ltd |
Rheumatoid arthritis treatment
|
|
WO2010115995A2
(en)
*
|
2009-04-10 |
2010-10-14 |
Ablynx Nv |
Improved amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders
|
|
EP2417163B1
(en)
*
|
2009-04-10 |
2019-02-27 |
Ablynx N.V. |
Improved amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders
|
|
DK2982690T3
(da)
|
2009-04-30 |
2021-04-12 |
Ablynx Nv |
Fremgangsmåde til fremstilling af domæne-antistoffer
|
|
MX340541B
(es)
|
2009-06-05 |
2016-07-13 |
Alblynx Nv |
Secuencias de aminoacidos mejoradas dirigidas contra virus sincitial respiratorio humano y polipeptidos que comprenden las mismas para la prevencion y/o tratamiento de infecciones del tracto respiratorio.
|
|
HUE051430T2
(hu)
|
2009-07-10 |
2021-03-01 |
Ablynx Nv |
Eljárás variábilis domének elõállítására
|
|
PT2473528E
(pt)
|
2009-09-03 |
2015-03-04 |
Ablynx NV |
Formulações estáveis de polipéptidos e seus usos
|
|
EP2475682B1
(en)
|
2009-09-10 |
2018-01-31 |
UCB Biopharma SPRL |
Multivalent antibodies
|
|
US20110172398A1
(en)
|
2009-10-02 |
2011-07-14 |
Boehringer Ingelheim International Gmbh |
Bispecific binding molecules for anti-angiogenesis therapy
|
|
UY32917A
(es)
|
2009-10-02 |
2011-04-29 |
Boehringer Ingelheim Int |
Moléculas de unión a dll-4
|
|
US20110117113A1
(en)
|
2009-10-09 |
2011-05-19 |
Gerald Beste |
Immunoglobulin single variable domain directed against human cxcr4 and other cell associated proteins and methods to generate them
|
|
US9644022B2
(en)
|
2009-11-30 |
2017-05-09 |
Ablynx N.V. |
Amino acid sequences directed against human respiratory syncytial virus (HRSV) and polypeptides comprising the same for the prevention and/or treatment of respiratory tract infections
|
|
WO2011067160A1
(en)
|
2009-12-01 |
2011-06-09 |
Ablynx Nv |
Von willebrand factor specific binding agents and uses thereof
|
|
US8962807B2
(en)
|
2009-12-14 |
2015-02-24 |
Ablynx N.V. |
Single variable domain antibodies against OX40L, constructs and therapeutic use
|
|
JO3417B1
(ar)
|
2010-01-08 |
2019-10-20 |
Regeneron Pharma |
الصيغ المستقرة التي تحتوي على الأجسام المضادة لمضاد مستقبل( interleukin-6 (il-6r
|
|
WO2011083140A1
(en)
|
2010-01-08 |
2011-07-14 |
Ablynx Nv |
Immunoglobulin single variable domain directed against human cxcr4
|
|
WO2011095545A1
(en)
|
2010-02-05 |
2011-08-11 |
Ablynx Nv |
Peptides capable of binding to serum albumin and compounds, constructs and polypeptides comprising the same
|
|
US9120855B2
(en)
|
2010-02-10 |
2015-09-01 |
Novartis Ag |
Biologic compounds directed against death receptor 5
|
|
EP2533814A2
(en)
|
2010-02-11 |
2012-12-19 |
Ablynx N.V. |
Delivery of immunoglobulin variable domains and constructs thereof
|
|
HRP20191071T1
(hr)
|
2010-02-11 |
2019-09-20 |
Ablynx N.V. |
Postupci i pripravci za pripremu aerosola
|
|
WO2011107507A1
(en)
|
2010-03-03 |
2011-09-09 |
Boehringer Ingelheim International Gmbh |
Biparatopic abeta binding polypeptides
|
|
WO2011117423A1
(en)
|
2010-03-26 |
2011-09-29 |
Ablynx N.V. |
Immunoglobulin single variable domains directed against cxcr7
|
|
US9556273B2
(en)
|
2010-03-29 |
2017-01-31 |
Vib Vzw |
Anti-macrophage mannose receptor single variable domains for targeting and in vivo imaging of tumor-associated macrophages
|
|
US9101674B2
(en)
|
2010-03-29 |
2015-08-11 |
Vib Vzw |
Targeting and in vivo imaging of tumor-associated macrophages
|
|
SG185354A1
(en)
|
2010-05-20 |
2012-12-28 |
Ablynx Nv |
Biological materials related to her3
|
|
HUE060454T2
(hu)
|
2010-05-28 |
2023-03-28 |
Chugai Pharmaceutical Co Ltd |
Daganatellenes T-sejt-választ fokozó szer
|
|
CA2802775C
(en)
*
|
2010-06-17 |
2019-09-24 |
Vib Vzw |
Increased protein expression through increased membrane formation
|
|
WO2011161263A1
(en)
|
2010-06-25 |
2011-12-29 |
Ablynx Nv |
Pharmaceutical compositions for cutaneous administration
|
|
US20120225081A1
(en)
|
2010-09-03 |
2012-09-06 |
Boehringer Ingelheim International Gmbh |
Vegf-binding molecules
|
|
US11644471B2
(en)
|
2010-09-30 |
2023-05-09 |
Ablynx N.V. |
Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains
|
|
WO2012042026A1
(en)
|
2010-09-30 |
2012-04-05 |
Ablynx Nv |
Biological materials related to c-met
|
|
KR101650995B1
(ko)
|
2010-11-08 |
2016-08-25 |
노파르티스 아게 |
Ｃｘｃｒ２ 결합 폴리펩티드
|
|
US20150158948A9
(en)
|
2011-03-28 |
2015-06-11 |
Francis Descamps |
Bispecific anti-cxcr7 immunoglobulin single variable domains
|
|
US9527925B2
(en)
|
2011-04-01 |
2016-12-27 |
Boehringer Ingelheim International Gmbh |
Bispecific binding molecules binding to VEGF and ANG2
|
|
US20130078247A1
(en)
|
2011-04-01 |
2013-03-28 |
Boehringer Ingelheim International Gmbh |
Bispecific binding molecules binding to dii4 and ang2
|
|
UA117218C2
(uk)
|
2011-05-05 |
2018-07-10 |
Мерк Патент Гмбх |
Поліпептид, спрямований проти il-17a, il-17f та/або il17-a/f
|
|
EP3590950A1
(en)
|
2011-05-09 |
2020-01-08 |
Ablynx NV |
Method for the production of immunoglobulin single varible domains
|
|
RU2661677C2
(ru)
|
2011-05-27 |
2018-07-18 |
Аблинкс Нв |
Ингибирование резорбции кости с помощью связывающих rank-l пептидов
|
|
ES2662372T3
(es)
|
2011-06-21 |
2018-04-06 |
Vib Vzw |
Dominios de unión dirigidos contra complejos GPCR:proteína G y usos derivados de los mismos
|
|
NZ780183A
(en)
|
2011-06-23 |
2024-12-20 |
Ablynx Nv |
Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains
|
|
EP2723771B1
(en)
|
2011-06-23 |
2019-09-11 |
Ablynx NV |
Serum albumin binding proteins
|
|
EP4350345A3
(en)
|
2011-06-23 |
2024-07-24 |
Ablynx N.V. |
Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobin single variable domains
|
|
JP2014525736A
(ja)
|
2011-06-23 |
2014-10-02 |
アブリンクス エン．ヴェー． |
ＩｇＥに対する免疫グロブリン単一可変ドメイン
|
|
EP3363813A1
(en)
|
2011-06-23 |
2018-08-22 |
Ablynx NV |
Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobin single variable domains
|
|
PE20141522A1
(es)
|
2011-08-17 |
2014-11-17 |
Glaxo Group Ltd |
Proteinas y peptidos modificados
|
|
WO2013041722A1
(en)
|
2011-09-23 |
2013-03-28 |
Ablynx Nv |
Prolonged inhibition of interleukin-6 mediated signaling
|
|
US9346884B2
(en)
|
2011-09-30 |
2016-05-24 |
Ablynx N.V. |
Biological materials related to c-Met
|
|
EP2747783B1
(en)
|
2011-09-30 |
2017-06-14 |
Ablynx N.V. |
Biological materials related to c-met
|
|
TWI589299B
(zh)
|
2011-10-11 |
2017-07-01 |
再生元醫藥公司 |
用於治療類風濕性關節炎之組成物及其使用方法
|
|
MX2014009129A
(es)
|
2012-01-26 |
2014-11-21 |
Amgen Inc |
Polipeptidos de factor 15 de diferenciacion de crecimiento (gdf-15).
|
|
UA115781C2
(uk)
|
2012-02-27 |
2017-12-26 |
Бьорінгер Інгельхайм Інтернаціональ Гмбх |
Cx3cr1-зв'язуючий поліпептид
|
|
CA2865464C
(en)
|
2012-03-30 |
2022-07-12 |
Boehringer Ingelheim International Gmbh |
Ang2-binding molecules
|
|
US9328174B2
(en)
|
2012-05-09 |
2016-05-03 |
Novartis Ag |
Chemokine receptor binding polypeptides
|
|
CA2874309C
(en)
|
2012-05-24 |
2021-06-15 |
Vib Vzw |
Anti-macrophage mannose receptor single variable domains for targeting and in vivo imaging of tumor-associated macrophages
|
|
WO2014087010A1
(en)
|
2012-12-07 |
2014-06-12 |
Ablynx N.V. |
IMPROVED POLYPEPTIDES DIRECTED AGAINST IgE
|
|
CN105102478A
(zh)
|
2013-01-30 |
2015-11-25 |
弗拉芒区生物技术研究所 |
用于筛选和药物发现目的的新型嵌合多肽
|
|
EP3590578A1
(en)
|
2013-02-05 |
2020-01-08 |
VIB vzw |
Muscarinic acetylcholine receptor binding agents and uses thereof
|
|
CA2906259C
(en)
|
2013-03-15 |
2022-12-06 |
Vib Vzw |
Anti-mmr single variable domains for prognosis and monitoring of cardiovascular diseases
|
|
EP3009518B1
(en)
|
2013-06-11 |
2020-08-12 |
National Center of Neurology and Psychiatry |
Method for predicting post-therapy prognosis of relapsing-remitting multiple sclerosis (rrms) patient, and method for determining applicability of novel therapy
|
|
US9862752B2
(en)
|
2013-07-31 |
2018-01-09 |
Amgen Inc. |
Growth differentiation factor 15 (GDF-15) constructs
|
|
US10017559B2
(en)
|
2013-11-04 |
2018-07-10 |
INSERM (Institut National de la Santé et de la Recherche Médicale |
Synthetic single domain antibody
|
|
EP2873680A1
(en)
*
|
2013-11-13 |
2015-05-20 |
F.Hoffmann-La Roche Ag |
Oligopeptide and methods for producing conjugates thereof
|
|
US9017678B1
(en)
|
2014-07-15 |
2015-04-28 |
Kymab Limited |
Method of treating rheumatoid arthritis using antibody to IL6R
|
|
WO2015097289A1
(en)
|
2013-12-24 |
2015-07-02 |
Vib Vzw |
Secretion and functional display of chimeric polypeptides
|
|
WO2015121092A1
(en)
|
2014-01-30 |
2015-08-20 |
Vib Vzw |
Opioid receptor binding agents and uses thereof
|
|
PT3248986T
(pt)
|
2014-05-16 |
2022-04-05 |
Ablynx Nv |
Domínios variáveis de imunoglobulina
|
|
EP3143403B1
(en)
|
2014-05-16 |
2021-10-27 |
Ablynx N.V. |
Methods for detecting and/or measuring anti-drug antibodies, in particular treatment-emergent anti-drug antibodies
|
|
KR20250099289A
(ko)
|
2014-05-16 |
2025-07-01 |
아블린쓰 엔.브이. |
개선된 면역글로불린 가변 도메인
|
|
NL2013007B1
(en)
|
2014-06-16 |
2016-07-05 |
Ablynx Nv |
Methods of treating TTP with immunoglobulin single variable domains and uses thereof.
|
|
NL2013661B1
(en)
|
2014-10-21 |
2016-10-05 |
Ablynx Nv |
KV1.3 Binding immunoglobulins.
|
|
CA2955554C
(en)
|
2014-07-22 |
2022-07-05 |
Vib Vzw |
Methods to select for agents that stabilize protein complexes
|
|
AU2015328370B2
(en)
|
2014-10-07 |
2021-08-05 |
Immunomedics, Inc. |
Neoadjuvant use of antibody-drug conjugates
|
|
US10118967B2
(en)
|
2014-10-21 |
2018-11-06 |
Ablynx N.V. |
Methods for treating rheumatoid arthritis by administering IL-6 receptor antibodies
|
|
JP6862343B2
(ja)
|
2014-12-19 |
2021-04-21 |
アブリンクス エン．ヴェー． |
システイン結合ナノボディダイマー
|
|
SG11201705093UA
(en)
|
2015-02-27 |
2017-07-28 |
Chugai Pharmaceutical Co Ltd |
Composition for treating il-6-related diseases
|
|
EP3271391A1
(en)
*
|
2015-03-20 |
2018-01-24 |
Ablynx N.V. |
Glycosylated immunoglobulin single variable domains
|
|
CA2981098A1
(en)
|
2015-03-31 |
2016-10-06 |
Vhsquared Limited |
Peptide construct having a protease-cleavable linker
|
|
HK1250040A1
(zh)
|
2015-03-31 |
2018-11-23 |
Sorriso Pharmaceuticals, Inc. |
多肽
|
|
ES3029413T3
(en)
|
2015-04-02 |
2025-06-24 |
Ablynx Nv |
Bispecific cxcr4-cd-4 polypeptides with potent anti-hiv activity
|
|
CA2981543A1
(en)
|
2015-04-22 |
2016-10-27 |
Immunomedics, Inc. |
Isolation, detection, diagnosis and/or characterization of circulating trop-2-positive cancer cells
|
|
EP3611192B1
(en)
|
2015-05-13 |
2025-03-05 |
Ablynx N.V. |
T cell recruiting polypeptides based on tcr alpha/beta reactivity
|
|
SI3294319T1
(sl)
|
2015-05-13 |
2024-09-30 |
Ablynx Nv |
Polipeptidi, ki rekrutirajo celice T na osnovi reaktivnosti CD3
|
|
JP6875683B2
(ja)
|
2015-05-19 |
2021-05-26 |
国立研究開発法人国立精神・神経医療研究センター |
多発性硬化症（ｍｓ）患者の新規治療適用判断方法
|
|
CN111234027A
(zh)
|
2015-05-21 |
2020-06-05 |
哈普恩治疗公司 |
三特异性结合蛋白质及使用方法
|
|
PL3316885T3
(pl)
|
2015-07-01 |
2021-12-06 |
Immunomedics, Inc. |
Immunokoniugaty przeciwciało-sn-38 z linkerem cl2a
|
|
NO2768984T3
(OSRAM)
|
2015-11-12 |
2018-06-09 |
|
|
|
EP3974449A1
(en)
|
2015-11-13 |
2022-03-30 |
Ablynx NV |
Improved serum albumin-binding immunoglobulin variable domains
|
|
HK1254952A1
(zh)
|
2015-11-18 |
2019-08-02 |
Merck Sharp & Dohme Llc |
Ctla4结合剂
|
|
CN120535622A
(zh)
|
2015-11-18 |
2025-08-26 |
埃博灵克斯股份有限公司 |
改进的血清白蛋白结合剂
|
|
SG10201911035QA
(en)
|
2015-11-18 |
2020-01-30 |
Merck Sharp & Dohme |
Pd1 and/or lag3 binders
|
|
CN109071639B
(zh)
|
2015-11-18 |
2022-07-08 |
默沙东公司 |
Pd1/ctla4结合剂
|
|
CA3006398A1
(en)
|
2015-11-27 |
2017-06-01 |
Ablynx Nv |
Polypeptides inhibiting cd40l
|
|
MA54648A
(fr)
|
2015-12-04 |
2021-11-10 |
Boehringer Ingelheim Int |
Polypeptides biparatopiques antagonistes de la signalisation wnt dans des cellules tumorales
|
|
WO2017125578A1
(en)
*
|
2016-01-21 |
2017-07-27 |
Vhsquared Limited |
Polypeptides
|
|
CA3017813C
(en)
|
2016-03-17 |
2021-12-07 |
Oslo Universitetssykehus Hf |
Fusion proteins targeting tumour associated macrophages for treating cancer
|
|
WO2017191108A1
(en)
|
2016-05-02 |
2017-11-09 |
Ablynx Nv |
Treatment of rsv infection
|
|
BR112018073739A2
(pt)
|
2016-05-20 |
2019-02-26 |
Harpoon Therapeutics, Inc. |
proteína de ligação de albumina sérica de domínio único
|
|
US11623958B2
(en)
|
2016-05-20 |
2023-04-11 |
Harpoon Therapeutics, Inc. |
Single chain variable fragment CD3 binding proteins
|
|
CN109641046B
(zh)
|
2016-05-20 |
2023-11-07 |
哈普恩治疗公司 |
单链可变片段cd3结合蛋白质
|
|
US11780924B2
(en)
|
2016-06-21 |
2023-10-10 |
University Of Oslo |
HLA binding vaccine moieties and uses thereof
|
|
CA3029133C
(en)
|
2016-06-23 |
2024-04-30 |
Ablynx N.V. |
Improved pharmacokinetic assays for immunoglobulin single variable domains
|
|
WO2018007442A1
(en)
|
2016-07-06 |
2018-01-11 |
Ablynx N.V. |
Treatment of il-6r related diseases
|
|
WO2018029182A1
(en)
|
2016-08-08 |
2018-02-15 |
Ablynx N.V. |
Il-6r single variable domain antibodies for treatment of il-6r related diseases
|
|
EP3512880A1
(en)
|
2016-09-15 |
2019-07-24 |
Ablynx NV |
Immunoglobulin single variable domains directed against macrophage migration inhibitory factor
|
|
US11136409B2
(en)
|
2016-09-20 |
2021-10-05 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for identification, assessment, prevention, and treatment of AML using USP10 biomarkers and modulators
|
|
EP3519438A1
(en)
|
2016-09-30 |
2019-08-07 |
VHsquared Limited |
Compositions
|
|
AU2017361846B2
(en)
|
2016-11-16 |
2024-08-22 |
Ablynx Nv |
T cell recruiting polypeptides capable of binding CD123 and TCR alpha/beta
|
|
JP7215997B2
(ja)
|
2016-11-23 |
2023-01-31 |
ハープーン セラピューティクス，インク． |
前立腺特異的膜抗原（ｐｓｍａ）を標的とする三重特異性タンパク質と使用方法
|
|
JP6812551B2
(ja)
|
2016-11-23 |
2021-01-13 |
ハープーン セラピューティクス，インク． |
前立腺特異的膜抗原結合タンパク質
|
|
CA3039316A1
(en)
|
2016-11-28 |
2018-05-31 |
Chugai Seiyaku Kabushiki Kaisha |
Ligand-binding molecule having adjustable ligand binding activity
|
|
WO2018099968A1
(en)
|
2016-11-29 |
2018-06-07 |
Ablynx N.V. |
Treatment of infection by respiratory syncytial virus (rsv)
|
|
CN117164710A
(zh)
|
2016-12-07 |
2023-12-05 |
埃博灵克斯股份有限公司 |
改进的血清白蛋白结合免疫球蛋白单可变结构域
|
|
WO2018111099A1
(en)
|
2016-12-12 |
2018-06-21 |
Stichting Vumc |
Biomarkers and treatments for cerebral amyloid angiopathy (caa)
|
|
SG10202108973SA
(en)
|
2017-01-17 |
2021-09-29 |
Ablynx Nv |
Improved serum albumin binders
|
|
ES2991459T3
(es)
|
2017-01-17 |
2024-12-03 |
Ablynx Nv |
Ligantes de albúmina sérica mejorados
|
|
US11535668B2
(en)
|
2017-02-28 |
2022-12-27 |
Harpoon Therapeutics, Inc. |
Inducible monovalent antigen binding protein
|
|
US11964002B2
(en)
|
2017-02-28 |
2024-04-23 |
Vib Vzw |
Means and methods for oral protein delivery
|
|
AU2018241286B2
(en)
|
2017-03-31 |
2025-03-13 |
Ablynx N.V. |
Improved immunogenicity assays
|
|
JP7185884B2
(ja)
|
2017-05-02 |
2022-12-08 |
国立研究開発法人国立精神・神経医療研究センター |
Ｉｌ－６及び好中球の関連する疾患の治療効果の予測及び判定方法
|
|
WO2018206734A1
(en)
|
2017-05-11 |
2018-11-15 |
Vib Vzw |
Glycosylation of variable immunoglobulin domains
|
|
CA3063362A1
(en)
|
2017-05-12 |
2018-11-15 |
Harpoon Therapeutics, Inc. |
Msln targeting trispecific proteins and methods of use
|
|
CA3063359A1
(en)
|
2017-05-12 |
2018-11-15 |
Harpoon Therapeutics, Inc. |
Mesothelin binding proteins
|
|
US11033636B2
(en)
|
2017-05-31 |
2021-06-15 |
Boehringer Ingelheim International Gmbh |
Polypeptides antagonizing Wnt signaling in tumor cells
|
|
KR102778120B1
(ko)
|
2017-06-02 |
2025-03-06 |
메르크 파텐트 게엠베하 |
Mmp13 결합성 면역글로불린
|
|
CN110997716B
(zh)
|
2017-06-02 |
2024-03-15 |
埃博灵克斯股份有限公司 |
结合聚集蛋白聚糖的免疫球蛋白
|
|
LT3630847T
(lt)
|
2017-06-02 |
2024-12-10 |
Merck Patent Gmbh |
Adamts surišantys imunoglobulinai
|
|
IL270951B2
(en)
|
2017-06-02 |
2025-05-01 |
Merck Patent Gmbh |
ADAMTS5, MMP13 and aggrecan-binding polypeptides
|
|
EP3634496A4
(en)
|
2017-06-06 |
2021-09-08 |
Dana-Farber Cancer Institute, Inc. |
METHODS FOR SENSITIZING CANCER CELLS TO T-LYMPHOCYTES-MEDIA DESTRUCTION BY MODULATION OF MOLECULAR PATHWAYS
|
|
GB201710973D0
(en)
|
2017-07-07 |
2017-08-23 |
Avacta Life Sciences Ltd |
Scaffold proteins
|
|
CA3070253A1
(en)
|
2017-07-19 |
2019-01-24 |
Vib Vzw |
Serum albumin binding agents
|
|
RU2020111737A
(ru)
|
2017-09-13 |
2021-10-13 |
Цзянсу Хэнжуй Медицин Ко., Лтд. |
Антитело против il-6r и его антигенсвязывающий фрагмент и медицинское применение
|
|
CN107492601A
(zh)
*
|
2017-09-30 |
2017-12-19 |
京东方科技集团股份有限公司 |
一种显示器件及其封装方法、显示装置
|
|
UA129446C2
(uk)
|
2017-10-13 |
2025-04-30 |
Гарпун Терап'Ютікс, Інк. |
Триспецифічні білки і способи їх застосування
|
|
IL315737A
(en)
|
2017-10-13 |
2024-11-01 |
Harpoon Therapeutics Inc |
B-cell maturation antigen-binding proteins
|
|
EP3698808B1
(en)
|
2017-10-20 |
2025-01-01 |
Hyogo College Of Medicine |
Anti-il-6 receptor antibody-containing medicinal composition for preventing post-surgical adhesion
|
|
WO2019086548A1
(en)
|
2017-10-31 |
2019-05-09 |
Vib Vzw |
Novel antigen-binding chimeric proteins and methods and uses thereof
|
|
CN118745229A
(zh)
|
2017-11-15 |
2024-10-08 |
诺和诺德股份有限公司 |
增强fx活化的因子x结合物
|
|
WO2019107384A1
(ja)
|
2017-11-28 |
2019-06-06 |
中外製薬株式会社 |
リガンド結合活性が調整可能なリガンド結合分子
|
|
BR112020010450A2
(pt)
|
2017-11-28 |
2020-11-24 |
Chugai Seiyaku Kabushiki Kaisha |
polipeptídeo que inclui domínio de ligação a antígeno e seção transportadora
|
|
IL276164B2
(en)
|
2018-01-26 |
2024-11-01 |
Regeneron Pharma |
Anti-tmprss2 antibodies and antigen-binding fragments
|
|
MY204220A
(en)
|
2018-02-06 |
2024-08-16 |
Ablynx Nv |
Methods of treating initial episode of ttp with immunoglobulin single variable domains
|
|
WO2019155041A1
(en)
|
2018-02-12 |
2019-08-15 |
Vib Vzw |
Gβγ COMPLEX ANTIBODIES AND USES THEREOF
|
|
AR114269A1
(es)
|
2018-02-26 |
2020-08-12 |
Ablynx Nv |
Secuencias nucleotídicas mejoradas que codifican para péptidos de unión
|
|
US20210032334A1
(en)
|
2018-02-28 |
2021-02-04 |
Dana-Farber Cancer Institute, Inc. |
Methods for treating cancer using combinations of anti-btnl2 and immune checkpoint blockade agents
|
|
EP3758742A1
(en)
|
2018-03-01 |
2021-01-06 |
Vrije Universiteit Brussel |
Human pd-l1-binding immunoglobulins
|
|
KR20200140878A
(ko)
|
2018-04-09 |
2020-12-16 |
암젠 인크 |
성장 분화 인자 15 융합 단백질
|
|
WO2019222283A1
(en)
|
2018-05-14 |
2019-11-21 |
Harpoon Therapeutics, Inc. |
Binding moiety for conditional activation of immunoglobulin molecules
|
|
US12195544B2
(en)
|
2018-09-21 |
2025-01-14 |
Harpoon Therapeutics, Inc. |
EGFR binding proteins and methods of use
|
|
EP3856771A4
(en)
|
2018-09-25 |
2022-06-29 |
Harpoon Therapeutics, Inc. |
Dll3 binding proteins and methods of use
|
|
EP3636657A1
(en)
|
2018-10-08 |
2020-04-15 |
Ablynx N.V. |
Chromatography-free antibody purification method
|
|
EP3917618A1
(en)
|
2019-01-31 |
2021-12-08 |
Sanofi Biotechnology |
Anti-il-6 receptor antibody for treating juvenile idiopathic arthritis
|
|
EP3935084B1
(en)
|
2019-03-08 |
2024-06-12 |
LinXis B.V. |
Internalizing binding molecules targeting receptors involved in cell proliferation or cell differentiation
|
|
EP3959240A1
(en)
|
2019-04-24 |
2022-03-02 |
Sanofi Biotechnology |
Methods of diagnosis and treatment of rheumatoid arthritis
|
|
SG11202111980QA
(en)
|
2019-04-29 |
2021-11-29 |
Confo Therapeutics N V |
Screening methods and assays for use with transmembrane proteins, in particular with gpcrs
|
|
US20220289854A1
(en)
|
2019-04-30 |
2022-09-15 |
Dana-Farber Cancer Institute, Inc. |
Methods for treating cancer using combinations of anti-cx3cr1 and immune checkpoint blockade agents
|
|
EP3962599A1
(en)
|
2019-04-30 |
2022-03-09 |
Vib Vzw |
Cystic fibrosis transmembrane conductance regulator stabilizing agents
|
|
WO2020239934A1
(en)
|
2019-05-28 |
2020-12-03 |
Vib Vzw |
Cd8+ t-cells lacking plexins and their application in cancer treatment
|
|
US20220220197A1
(en)
|
2019-05-28 |
2022-07-14 |
Vib Vzw |
Cancer Treatment by Targeting Plexins in the Immune Compartment
|
|
AU2020288561A1
(en)
|
2019-06-04 |
2021-12-23 |
Regeneron Pharmaceuticals, Inc. |
Compositions and methods for treating pain in subjects with rheumatoid arthritis
|
|
AU2020294980A1
(en)
|
2019-06-21 |
2022-02-17 |
Sorriso Pharmaceuticals, Inc. |
Polypeptides
|
|
EP3986931A1
(en)
|
2019-06-21 |
2022-04-27 |
Sorriso Pharmaceuticals, Inc. |
Polypeptides
|
|
KR20220128332A
(ko)
|
2019-09-20 |
2022-09-20 |
잉벡띠스 에스에이에스 |
Lilrb2에 대항하는 단일-도메인 항체
|
|
TW202128775A
(zh)
|
2019-10-16 |
2021-08-01 |
英商阿法克塔生命科學有限公司 |
PD-L1抑制劑-TGFβ抑制劑雙特異性藥物部分
|
|
WO2021078786A1
(en)
|
2019-10-21 |
2021-04-29 |
Vib Vzw |
Nanodisc-specific antigen-binding chimeric proteins
|
|
BR112022009087A2
(pt)
|
2019-11-11 |
2022-07-26 |
Ibi Ag Innovative Bio Insecticides Ltd |
Nanocorpos para controle de insetos e usos dos mesmos
|
|
WO2021105438A1
(en)
|
2019-11-27 |
2021-06-03 |
Vib Vzw |
Positive allosteric modulators of the calcium-sensing receptor
|
|
WO2021113736A1
(en)
|
2019-12-05 |
2021-06-10 |
Massachusetts Institute Of Technology |
Single-domain antibody to chloramphenicol
|
|
CA3163764A1
(en)
|
2019-12-06 |
2021-06-10 |
Ablynx Nv |
Polypeptides comprising immunoglobulin single variable domains targeting tnfa and ox40l
|
|
CN114981300B
(zh)
|
2019-12-06 |
2025-10-31 |
艾伯霖克斯公司 |
包含靶向TNFα和IL-23的免疫球蛋白单个可变结构域的多肽
|
|
AU2020400938A1
(en)
|
2019-12-09 |
2022-07-28 |
Ablynx Nv |
Polypeptides comprising immunoglobulin single variable domains targeting IL-13 and TSLP
|
|
GB201918279D0
(en)
|
2019-12-12 |
2020-01-29 |
Vib Vzw |
Glycosylated single chain immunoglobulin domains
|
|
EP4077372A1
(en)
|
2019-12-20 |
2022-10-26 |
Vib Vzw |
Nanobody exchange chromatography
|
|
WO2021140205A1
(en)
|
2020-01-10 |
2021-07-15 |
Confo Therapeutics N.V. |
Methods for generating antibodies and antibody fragments and libraries comprising same
|
|
EP4093513A4
(en)
|
2020-01-24 |
2024-05-08 |
Dana-Farber Cancer Institute, Inc. |
USE OF BIOMARKERS TO IMPROVE IMMUNOTHERAPY
|
|
WO2021156490A2
(en)
|
2020-02-06 |
2021-08-12 |
Vib Vzw |
Corona virus binders
|
|
IL294529A
(en)
|
2020-02-10 |
2022-09-01 |
Regeneron Pharma |
Anti-tmprss2 antibodies and antigen-binding fragments
|
|
IL295448A
(en)
|
2020-02-21 |
2022-10-01 |
Harpoon Therapeutics Inc |
flt3 binding proteins and methods of use
|
|
JP2023514654A
(ja)
|
2020-02-25 |
2023-04-06 |
ブイアイビー ブイゼットダブリュ |
ロイシンリッチリピートキナーゼ２のアロステリック調節因子
|
|
EP4126971A1
(en)
|
2020-03-30 |
2023-02-08 |
Ablynx N.V. |
Method for the production and purification of multivalent immunoglobulin single variable domains
|
|
US10787501B1
(en)
|
2020-04-02 |
2020-09-29 |
Regeneron Pharmaceuticals, Inc. |
Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments
|
|
US20230279115A1
(en)
|
2020-04-22 |
2023-09-07 |
Mabwell (shanghai) Bioscience Co., Ltd. |
Single variable domain antibody targeting human programmed death ligand 1 (pd-l1) and derivative thereof
|
|
CN115667297A
(zh)
*
|
2020-05-18 |
2023-01-31 |
博奥信生物技术（南京）有限公司 |
结合il6r的抗体及其用途
|
|
JP2023527352A
(ja)
|
2020-05-26 |
2023-06-28 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
抗ｓａｒｓ－ｃｏｖ－２－スパイク糖タンパク質抗体及び抗原結合断片
|
|
GB202101299D0
(en)
|
2020-06-09 |
2021-03-17 |
Avacta Life Sciences Ltd |
Diagnostic polypetides and methods
|
|
WO2022003156A1
(en)
|
2020-07-02 |
2022-01-06 |
Oncurious Nv |
Ccr8 non-blocking binders
|
|
US20240325562A1
(en)
|
2020-09-16 |
2024-10-03 |
Linxis B.V. |
Internalizing binding molecules
|
|
WO2022063947A1
(en)
|
2020-09-24 |
2022-03-31 |
Vib Vzw |
Combination of p2y6 inhibitors and immune checkpoint inhibitors
|
|
WO2022063957A1
(en)
|
2020-09-24 |
2022-03-31 |
Vib Vzw |
Biomarker for anti-tumor therapy
|
|
CA3195687A1
(en)
|
2020-09-25 |
2022-03-31 |
Ablynx Nv |
Polypeptides comprising immunoglobulin single variable domains targeting il-13 and ox40l
|
|
CA3196434A1
(en)
|
2020-10-23 |
2022-04-28 |
Krista K. JOHNSON |
Methods of treating patients having complement disorders using anti-c5 antibodies
|
|
JP2024508207A
(ja)
|
2020-12-02 |
2024-02-26 |
ブイアイビー ブイゼットダブリュ |
がんに対する組み合わせ治療におけるｌｔｂｒアゴニスト
|
|
WO2022117569A1
(en)
|
2020-12-02 |
2022-06-09 |
Oncurious Nv |
A ccr8 antagonist antibody in combination with a lymphotoxin beta receptor agonist antibody in therapy against cancer
|
|
PH12023500013A1
(en)
|
2020-12-04 |
2024-03-11 |
Tidal Therapeutics Inc |
Ionizable cationic lipids and lipi nanoparticles, and methods of synthesis and use thereof
|
|
US11946055B2
(en)
*
|
2020-12-10 |
2024-04-02 |
The Regents Of The University Of California |
Protein engineering via error-prone orthogonal replication and yeast surface display
|
|
WO2022129637A1
(en)
|
2020-12-18 |
2022-06-23 |
Ablynx Nv |
T cell recruiting polypeptides based on tcr alpha/beta reactivity
|
|
KR20230123497A
(ko)
|
2020-12-18 |
2023-08-23 |
아블린쓰 엔.브이. |
IL-6 및 TNF-α를 표적화하는 면역글로불린 단일 가변도메인을 포함하는 폴리펩티드
|
|
IL303783A
(en)
|
2020-12-18 |
2023-08-01 |
Sanofi Sa |
Polypeptides comprising immunoglobulin single variable domains targeting glypican-3 and t cell receptor
|
|
GB202020502D0
(en)
|
2020-12-23 |
2021-02-03 |
Vib Vzw |
Antibody composistion for treatment of corona virus infection
|
|
EP4267617A1
(en)
|
2020-12-24 |
2023-11-01 |
Vib Vzw |
Human ccr8 binders
|
|
WO2022136650A1
(en)
|
2020-12-24 |
2022-06-30 |
Oncurious Nv |
Murine cross-reactive human ccr8 binders
|
|
EP4267618A1
(en)
|
2020-12-24 |
2023-11-01 |
Vib Vzw |
Non-blocking human ccr8 binders
|
|
WO2022159793A2
(en)
|
2021-01-25 |
2022-07-28 |
Dana-Farber Cancer Institute, Inc. |
Methods and compositions for identifying neuroendocrine prostate cancer
|
|
CN117794566A
(zh)
|
2021-02-05 |
2024-03-29 |
Vib研究所 |
沙贝病毒结合剂
|
|
KR20230141853A
(ko)
|
2021-02-05 |
2023-10-10 |
브이아이비 브이지더블유 |
사베코바이러스 결합제
|
|
WO2022173932A1
(en)
|
2021-02-11 |
2022-08-18 |
Dana-Farber Cancer Institute, Inc. |
Methods of treating cancers using sting agonists
|
|
CA3211257A1
(en)
|
2021-02-17 |
2022-08-25 |
Vib Vzw |
Inhibition of slc4a4 in the treatment of cancer
|
|
EP4294516A1
(en)
|
2021-02-19 |
2023-12-27 |
Vib Vzw |
Cation-independent mannose-6-phosphate receptor binders
|
|
CA3209052A1
(en)
|
2021-02-19 |
2022-08-25 |
Rafael Cristian CASELLAS |
Single domain antibodies that neutralize sars-cov-2
|
|
CN117425674A
(zh)
|
2021-03-02 |
2024-01-19 |
丹娜法伯癌症研究院 |
治疗红细胞疾患的方法
|
|
WO2022187626A1
(en)
|
2021-03-05 |
2022-09-09 |
Regeneron Pharmaceuticals, Inc. |
Anti-sars-cov-2-variant-spike glycoprotein antibodies and antigen-binding fragments
|
|
EP4319800A1
(en)
|
2021-04-07 |
2024-02-14 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for the treatment of cancer
|
|
WO2022234003A1
(en)
|
2021-05-07 |
2022-11-10 |
Avacta Life Sciences Limited |
Cd33 binding polypeptides with stefin a protein
|
|
WO2022261183A2
(en)
|
2021-06-08 |
2022-12-15 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for treating and/or identifying an agent for treating intestinal cancers
|
|
WO2022268993A1
(en)
|
2021-06-23 |
2022-12-29 |
Vib Vzw |
Means and methods for selection of specific binders
|
|
BR112024000744A2
(pt)
|
2021-07-14 |
2024-04-30 |
Regeneron Pharma |
Anticorpos de glicoprotéina spike anti-sars-cov-2 e fragmentos de ligação a antígeno
|
|
EP4377352A2
(en)
|
2021-07-30 |
2024-06-05 |
Vib Vzw |
Cation-independent mannose-6-phosphate receptor binders for targeted protein degradation
|
|
EP4413038A1
(en)
|
2021-10-07 |
2024-08-14 |
Avacta Life Sciences Limited |
Pd-l1 binding affimers
|
|
TW202332694A
(zh)
|
2021-10-07 |
2023-08-16 |
英商阿凡克塔生命科學公司 |
血清半衰期延長之ｐｄ－ｌ１結合多肽
|
|
CN114085287B
(zh)
*
|
2021-11-12 |
2022-10-25 |
中国农业科学院北京畜牧兽医研究所 |
犬细小病毒纳米抗体cpv-vhh-f5及其应用
|
|
US20250011767A1
(en)
|
2021-11-18 |
2025-01-09 |
Circularis Biotechnologies, Inc. |
Compositions and methods for production of circular nucleic acid molecules
|
|
EP4437547A1
(en)
|
2021-11-22 |
2024-10-02 |
Ablynx N.V. |
Obtaining sequence information for target multivalent immunoglobulin single variable domains
|
|
EP4440594A2
(en)
|
2021-11-29 |
2024-10-09 |
Dana-Farber Cancer Institute, Inc. |
Methods and compositions to modulate riok2
|
|
EP4448574A1
(en)
|
2021-12-17 |
2024-10-23 |
Ablynx N.V. |
Polypeptides comprising immunoglobulin single variable domains targeting tcralphabeta, cd33 and cd123
|
|
EP4463479A1
(en)
|
2022-01-12 |
2024-11-20 |
Vib Vzw |
Human ntcp binders for therapeutic use and liver-specific targeted delivery
|
|
WO2023148397A1
(en)
|
2022-02-07 |
2023-08-10 |
Vib Vzw |
Engineered stabilizing aglycosylated fc-regions
|
|
CN119213021A
(zh)
|
2022-02-10 |
2024-12-27 |
艾菲赛尔治疗株式会社 |
与CD40L特异性结合的Stefin A蛋白变体及其用途
|
|
TW202337497A
(zh)
|
2022-02-18 |
2023-10-01 |
中國大陸商重慶明道浩悅生物科技有限公司 |
鼻內調配物及抗sars-cov-2棘蛋白抗體
|
|
EP4508082A1
(en)
|
2022-04-13 |
2025-02-19 |
Vib Vzw |
An ltbr agonist in combination therapy against cancer
|
|
WO2023215498A2
(en)
*
|
2022-05-05 |
2023-11-09 |
Modernatx, Inc. |
Compositions and methods for cd28 antagonism
|
|
WO2023218243A1
(en)
|
2022-05-12 |
2023-11-16 |
Avacta Life Sciences Limited |
Lag-3/pd-l1 binding fusion proteins
|
|
US20250313611A1
(en)
|
2022-05-18 |
2025-10-09 |
Vib Vzw |
Sarbecovirus spike s2 subunit binders
|
|
WO2023240156A1
(en)
|
2022-06-08 |
2023-12-14 |
Tidal Therapeutics, Inc. |
Ionizable cationic lipids and lipid nanoparticles, and methods of synthesis and use thereof
|
|
US20240109965A1
(en)
|
2022-06-14 |
2024-04-04 |
Ablynx N.V. |
Immunoglobulin single variable domains targeting t cell receptor
|
|
JP2025523630A
(ja)
|
2022-07-04 |
2025-07-23 |
ブイアイビー ブイゼットダブリュ |
血液－脳脊髄液関門通過抗体
|
|
KR20250040019A
(ko)
|
2022-07-18 |
2025-03-21 |
아블린쓰 |
Cx3cr1 결합 화합물, 이의 용도, 및 관련 방법
|
|
JP2025526384A
(ja)
|
2022-07-27 |
2025-08-13 |
アブリンクス エン．ヴェー． |
新生児型Ｆｃ受容体の特異的エピトープに結合するポリペプチド
|
|
CN116162160B
(zh)
*
|
2022-08-05 |
2025-07-29 |
南京融捷康生物科技有限公司 |
一种抗il-6的单域抗体及其用途
|
|
EP4577578A1
(en)
|
2022-08-22 |
2025-07-02 |
Abdera Therapeutics Inc. |
Dll3 binding molecules and uses thereof
|
|
WO2024068744A1
(en)
|
2022-09-27 |
2024-04-04 |
Vib Vzw |
Antivirals against human parainfluenza virus
|
|
TW202430561A
(zh)
|
2022-09-30 |
2024-08-01 |
法商賽諾菲公司 |
抗cd28抗體
|
|
WO2024083843A1
(en)
|
2022-10-18 |
2024-04-25 |
Confo Therapeutics N.V. |
Amino acid sequences directed against the melanocortin 4 receptor and polypeptides comprising the same for the treatment of mc4r-related diseases and disorders
|
|
KR20250094703A
(ko)
|
2022-10-25 |
2025-06-25 |
아블린쓰 엔.브이. |
향상된 효과기 기능을 갖는 당조작된 Fc 변이체 폴리펩타이드
|
|
CN120457128A
(zh)
|
2022-11-09 |
2025-08-08 |
默克专利股份公司 |
作为免疫刺激剂以引发先天抗肿瘤免疫的Toll样受体7激动剂
|
|
US12195546B2
(en)
|
2022-12-19 |
2025-01-14 |
Sanofi |
CD28/OX40 bispecific antibodies
|
|
EP4638502A2
(en)
|
2022-12-21 |
2025-10-29 |
Genzyme Corporation |
Anti-pd-1×4-1bb binding proteins
|
|
TW202440614A
(zh)
|
2022-12-23 |
2024-10-16 |
比利時商艾伯霖克斯公司 |
基於蛋白質的接合載體
|
|
AU2024207151A1
(en)
|
2023-01-09 |
2025-06-19 |
Odyssey Therapeutics, Inc. |
Anti-tnfr2 antigen-binding proteins and uses thereof
|
|
WO2024156888A1
(en)
|
2023-01-27 |
2024-08-02 |
Vib Vzw |
Cd163-binding conjugates
|
|
EP4655323A1
(en)
|
2023-01-27 |
2025-12-03 |
Vrije Universiteit Brussel |
Cd8b-binding polypeptides
|
|
CN121013866A
(zh)
|
2023-02-10 |
2025-11-25 |
阿穆尼克斯制药公司 |
靶向前列腺特异性膜抗原（psma）的组合物及其制备和使用方法
|
|
TW202448926A
(zh)
|
2023-02-17 |
2024-12-16 |
比利時商艾伯霖克斯公司 |
結合新生兒fc受體之多肽
|
|
WO2024175787A1
(en)
|
2023-02-24 |
2024-08-29 |
Vrije Universiteit Brussel |
Anti-inflammatory pannexin 1 channel inhibitors
|
|
TW202444757A
(zh)
|
2023-03-14 |
2024-11-16 |
美商奧迪希治療公司 |
抗cd25抗原結合蛋白及其用途
|
|
AU2024240129A1
(en)
|
2023-03-17 |
2025-10-09 |
Oxitope Pharma B.V. |
Anti-phosphocholine antibodies and methods of use thereof
|
|
WO2024194685A2
(en)
|
2023-03-17 |
2024-09-26 |
Oxitope Pharma B.V. |
Anti-phosphocholine antibodies and methods of use thereof
|
|
WO2024200987A1
(en)
|
2023-03-31 |
2024-10-03 |
Avacta Life Sciences Limited |
Tnfr2 binding polypeptides and methods of use
|
|
FR3147278A1
(fr)
|
2023-03-31 |
2024-10-04 |
Avacta Life Sciences Limited |
Polypeptides de liaison au tnfr2 et procedes d'utilisation
|
|
AU2024243709A1
(en)
|
2023-04-03 |
2025-11-06 |
Katholieke Universiteit Leuven |
Blood-brain barrier crossing antibodies
|
|
WO2024226410A1
(en)
|
2023-04-24 |
2024-10-31 |
Merck Sharp & Dohme Llc |
Trop2 binders and conjugates thereof
|
|
CN121079319A
(zh)
|
2023-05-08 |
2025-12-05 |
赛诺菲 |
免疫球蛋白单可变结构域的糖基化
|
|
WO2024231348A1
(en)
|
2023-05-11 |
2024-11-14 |
Vib Vzw |
Slc4a4/nbce1 inhibitors
|
|
TW202448951A
(zh)
|
2023-05-17 |
2024-12-16 |
美商奧迪希治療公司 |
經修飾之單域抗體
|
|
WO2024251783A1
(en)
|
2023-06-05 |
2024-12-12 |
Sanofi |
Predicting thermal stabilities of immunoglobulin single variable domains using machine-learning models
|
|
WO2024261235A1
(en)
|
2023-06-22 |
2024-12-26 |
Ablynx Nv |
Chimeric proteins for modulating cytokine receptor activity
|
|
AR133055A1
(es)
|
2023-06-22 |
2025-08-20 |
Ablynx Nv |
Dominios variables únicos de inmunoglobulina dirigidos a pd-l1
|
|
WO2024261344A1
(en)
|
2023-06-23 |
2024-12-26 |
Vib Vzw |
Novel binders targeting the multi-drug resistant pathogen acinetobacter baumannii
|
|
TW202515917A
(zh)
|
2023-06-29 |
2025-04-16 |
美商奧迪希治療公司 |
抗trailr2抗原結合蛋白及其用途
|
|
AR133188A1
(es)
|
2023-07-05 |
2025-09-03 |
Ablynx Nv |
ANTAGONISTAS DE FcRn MEJORADOS PARA EL TRATAMIENTO DE ENFERMEDADES Y TRASTORNOS RELACIONADOS CON IgG
|
|
US20250051434A1
(en)
|
2023-08-11 |
2025-02-13 |
Merck Sharp & Dohme Llc |
Monovalent interleukin 12 (il-12) heterodimeric fc proteins
|
|
WO2025041077A1
(en)
|
2023-08-23 |
2025-02-27 |
Sanofi |
Ctla-4-based lysosomal degraders and uses thereof
|
|
WO2025051767A1
(en)
|
2023-09-04 |
2025-03-13 |
Sanofi |
Polypeptides for use in the treatment of glypican-3-expressing tumours
|
|
AR133903A1
(es)
|
2023-09-22 |
2025-11-12 |
Ablynx Nv |
Agentes de unión de albúmina bi- y multivalentes
|
|
TW202530265A
(zh)
|
2023-10-13 |
2025-08-01 |
美商奧迪希治療公司 |
抗cdh17抗原結合蛋白及其用途
|
|
WO2025088546A1
(en)
|
2023-10-25 |
2025-05-01 |
Ablynx N.V. |
Fc domain variants with enhanced fc receptor binding
|
|
WO2025093683A1
(en)
|
2023-11-03 |
2025-05-08 |
Neuvasq Biotechnologies Sa |
Wnt7 signaling agonists
|
|
WO2025099632A1
(en)
|
2023-11-08 |
2025-05-15 |
Sanofi |
Cd25 based lysosomal degrader and uses thereof
|
|
WO2025109176A1
(en)
|
2023-11-22 |
2025-05-30 |
Exevir Bio Bv |
Optimized sarbecovirus spike s2 subunit binders and compositions comprising the same
|
|
WO2025114555A1
(en)
|
2023-11-30 |
2025-06-05 |
Oncospear Aps |
Anti-cd163 antibodies with improved adcc capabilities
|
|
WO2025114529A1
(en)
|
2023-12-01 |
2025-06-05 |
Ablynx Nv |
Multispecific antibodies recognising human serum albumin, tcr and a tumor antigen recognising moiety
|
|
WO2025125577A1
(en)
|
2023-12-14 |
2025-06-19 |
Vib Vzw |
Antibodies against influenza b virus
|
|
WO2025133252A1
(en)
|
2023-12-22 |
2025-06-26 |
Ablynx Nv |
Immunoglobulin single variable domains targeting ceacam5
|
|
WO2025133253A2
(en)
|
2023-12-22 |
2025-06-26 |
Ablynx Nv |
Protein-based conjugation carriers for intranuclear delivery
|
|
US20250236673A1
(en)
|
2023-12-22 |
2025-07-24 |
Ablynx N.V. |
Protein-based carriers for site-specific amine conjugation
|
|
WO2025154056A1
(en)
|
2024-01-21 |
2025-07-24 |
Ibi-Ag Innovative Bio Insecticides Ltd. |
Anti-insect cda nanobodies and uses thereof
|
|
WO2025154058A1
(en)
|
2024-01-21 |
2025-07-24 |
Ibi-Ag Innovative Bio Insecticides Ltd. |
Anti-insect hsp70 nanobodies and uses thereof
|
|
WO2025174825A2
(en)
|
2024-02-12 |
2025-08-21 |
Aera Therapeutics, Inc. |
Delivery compositions
|
|
WO2025181155A1
(en)
|
2024-02-26 |
2025-09-04 |
Vib Vzw |
Human beta-glucocerebrosidase binders and uses thereof
|
|
GB202403780D0
(en)
|
2024-03-15 |
2024-05-01 |
Avacta Life Sciences Ltd |
Polypeptides and methods for detecting and quantifying small molecules
|
|
WO2025196308A1
(en)
|
2024-03-22 |
2025-09-25 |
Vib Vzw |
Means and methods for displaying fc-containing proteins on cells and selection thereof
|
|
WO2025207946A1
(en)
|
2024-03-28 |
2025-10-02 |
Genzyme Corporation |
Polypeptides binding to a specific epitope of the transferrin receptor 1
|
|
WO2025217240A1
(en)
|
2024-04-10 |
2025-10-16 |
Odyssey Therapeutics, Inc. |
Anti-tnfr2 antigen-binding proteins and uses thereof
|
|
WO2025219231A1
(en)
|
2024-04-15 |
2025-10-23 |
Vib Vzw |
Computer-implemented means and methods for the de novo design of antibodies targeting a specific epitope
|
|
WO2025229159A1
(en)
|
2024-05-01 |
2025-11-06 |
Commit Biologics Aps |
Antibodies and antibody constructs against cd20
|
|
WO2025238157A1
(en)
|
2024-05-15 |
2025-11-20 |
Katholieke Universiteit Leuven |
Multispecific binding agent suitable for use in cancer immune therapy
|